Skip to content

Basic & Clinical Pharmacology & Toxicology

ISSN 1742-7843

6 papers in the library · 6 citations · publishing 2008-2026

Papers

Sort Most recent Most cited

Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets

Basic & Clinical Pharmacology & Toxicology March 11, 2026 Chendi Zhao, Yang Wang, Jinglang Wu et al.

Esketamine (ESK), the dextrorotatory enantiomer of ketamine, is an antagonist of the N-methyl-D-aspartic acid (NMDA) receptor. ESK is considered an effective anesthetic because of its ability to mitigate postoperative pain and opioid use. Recently, it has attracted significant research attention for its fast-acting antidepressant effects. Given the advantages of ESK in both perioperative and...

DOI: 10.1111/bcpt.70221 (opens in new tab) Ketamine Neuroprotection Central nervous system Pharmacology +9

Development of a Brief Mindfulness-Informed Cognitive Behavioral Therapy Intervention to Pair with Pharmacist-Led Benzodiazepine Tapering for Older Adults: The CSTARS Intervention

Basic & Clinical Pharmacology & Toxicology October 9, 2025 Kristen M. Kraemer, Brianna X Wang, Marissa L McCann et al.

Benzodiazepines are potentially inappropriate medications for older adults, and deprescribing interventions are needed. We describe the development of a psychologist‐led, mindfulness‐informed cognitive–behavioural therapy (CBT) intervention to pair with pharmacist‐led tapering to support benzodiazepine deprescribing in older adults. Based on previous research, we first developed an intervention...

Rapid-acting antidepressants and the regulation of TrkB neurotrophic signalling-Insights from ketamine, nitrous oxide, seizures and anaesthesia.

Basic & Clinical Pharmacology & Toxicology August 1, 2021 Samuel Kohtala, Tomi Rantamäki

Increased glutamatergic neurotransmission and synaptic plasticity in the prefrontal cortex have been associated with the rapid antidepressant effects of ketamine. Activation of BDNF (brain-derived neurotrophic factor) receptor TrkB is considered a key molecular event for antidepressant-induced functional and structural synaptic plasticity. Several mechanisms have been proposed to underlie...

DOI: 10.1111/bcpt.13598 (opens in new tab) Full text (opens in new tab) Electroencephalogram Energy metabolism Protein phosphorylation Rapid-acting antidepressant +1

Dopamine D1Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA

Basic & Clinical Pharmacology & Toxicology October 4, 2011 Natacha Vanattou‐saïfoudine, Brendan Behan, Andrew Harkin 6 citations

Markers of dopamine D(1) receptor activation were determined to elucidate intracellular mechanisms associated with the combined effects of caffeine and 3,4 methylenedioxymethamphetamine (MDMA), reported previously to produce increased toxicity, when compared with either drug alone. Caffeine (10 mg/kg) and MDMA (15 mg/kg) were administered to male Sprague Dawley rats alone and in combination....

Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.

Basic & Clinical Pharmacology & Toxicology December 2008 Lêda S B Garcia, Clarissa M Comim, Samira S Valvassori et al.

A growing body of evidence has pointed to the blockade of the N-methyl-d-aspartate (NMDA) receptor signaling as a potential therapeutic target for the treatment of major depression. The present study was aimed to evaluate behavioural and molecular effects of the chronic treatment with ketamine and imipramine in rats. To this aim, rats were 14 days treated once a day with ketamine (5, 10 and 15...

The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

Basic & Clinical Pharmacology & Toxicology January 2008 Sunniva Nyberg Karlsen, Olav Spigset, Lars Slørdal

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a known neurotoxin in animals. This review discusses the history, pattern of use, pharmacology, acute and long-term effects of MDMA. Emphasis is given to the concern that MDMA may induce long-term cognitive and psychiatric effects. MDMA is an illegal substance, and investigations of the effects of exposure in human beings have limitations and...